Inventor · disambiguated record
Carl H. June
Also filed as: JUNE CARL · JUNE CARL H
133 granted patents·96 pending applications·15,095 citations·filing 1994–2025
99Inventor score
Top patents by PatentIndex Score
229 records- 0199US9540445B2Compositions and methods for treatment of cancerUNIV PENNSYLVANIA·Filed 2016·Granted Jan 10, 2017·99 cites·30 claims
- 0299US9518123B2Compositions and methods for treatment of cancerUNIV PENNSYLVANIA·Filed 2016·Granted Dec 13, 2016·92 cites·26 claims
- 0399US9481728B2Compositions and methods for treatment of cancerUNIV PENNSYLVANIA·Filed 2015·Granted Nov 1, 2016·100 cites·30 claims
- 0499US9464140B2Compositions and methods for treatment of cancerUNIV PENNSYLVANIA·Filed 2016·Granted Oct 11, 2016·117 cites·28 claims
- 0599US9328156B2Use of chimeric antigen receptor-modified T cells to treat cancerUNIV PENNSYLVANIA·Filed 2013·Granted May 3, 2016·127 cites·15 claims
- 0699US9102761B2Compositions for treatment of cancerUNIV PENNSYLVANIA·Filed 2014·Granted Aug 11, 2015·250 cites·30 claims
- 0799US9102760B2Compositions for treatment of cancerUNIV PENNSYLVANIA·Filed 2014·Granted Aug 11, 2015·254 cites·30 claims
- 0899US9101584B2Methods for treatment of cancerUNIV PENNSYLVANIA·Filed 2014·Granted Aug 11, 2015·250 cites·30 claims
- 0999US8975071B1Compositions for treatment of cancerUNIV PENNSYLVANIA·Filed 2014·Granted Mar 10, 2015·255 cites·17 claims
- 1099US8916381B1Methods for treatment of cancerUNIV PENNSYLVANIA·Filed 2014·Granted Dec 23, 2014·276 cites·28 claims
- 1199US8911993B2Compositions for treatment of cancerUNIV PENNSYLVANIA·Filed 2013·Granted Dec 16, 2014·474 cites·21 claims
- 1299US8906682B2Methods for treatment of cancerUNIV PENNSYLVANIA·Filed 2013·Granted Dec 9, 2014·507 cites·30 claims
- 1399US7232566B2Methods for treating HIV infected subjectsGENETICS INST LLC·Filed 2005·Granted Jun 19, 2007·814 cites·64 claims
- 1499US7175843B2Methods for selectively stimulating proliferation of T cellsUS NAVY·Filed 2006·Granted Feb 13, 2007·821 cites·65 claims
- 1599US7144575B2Methods for selectively stimulating proliferation of T cellsUS NAVY·Filed 2003·Granted Dec 5, 2006·799 cites·24 claims
- 1699US6905681B1Methods for selectively stimulating proliferation of T cellsINST GENETICS LLC·Filed 1999·Granted Jun 14, 2005·913 cites·18 claims
- 1799US6905680B2Methods of treating HIV infected subjectsUS NAVY·Filed 1996·Granted Jun 14, 2005·879 cites·14 claims
- 1899US6887466B2Methods for selectively stimulating proliferation of T cellsUS NAVY·Filed 1999·Granted May 3, 2005·914 cites·19 claims
- 1999US6534055B1Methods for selectively stimulating proliferation of T cellsGENETICS INST·Filed 1995·Granted Mar 18, 2003·1k cites·29 claims
- 2099US6352694B1Methods for inducing a population of T cells to proliferate using agents which recognize TCR/CD3 and ligands which stimulate an accessory molecule on the surface of the T cellsGENETICS INST·Filed 1995·Granted Mar 5, 2002·1.2k cites·32 claims
- 2199US5858358AMethods for selectively stimulating proliferation of T cellsUS NAVY·Filed 1994·Granted Jan 12, 1999·885 cites·33 claims
- 2298US9499629B2Use of chimeric antigen receptor-modified T-cells to treat cancerJUNE CARL H·Filed 2011·Granted Nov 22, 2016·151 cites·53 claims
- 2398US7172869B2Methods for transfecting T cellsUNIV MICHIGAN·Filed 2004·Granted Feb 6, 2007·707 cites·51 claims
- 2498US7067318B2Methods for transfecting T cellsUS NAVY·Filed 2003·Granted Jun 27, 2006·701 cites·47 claims
- 2598US6692964B1Methods for transfecting T cellsUS NAVY·Filed 1995·Granted Feb 17, 2004·765 cites·19 claims
- 2697US11161907B2Car-expressing cells against multiple tumor antigens and uses thereofNOVARTIS AG·Filed 2016·Granted Nov 2, 2021·19 cites·35 claims
- 2797US10696749B2Enhancing activity of CAR T cells by co-introducing a bispecific antibodyUNIV PENNSYLVANIA·Filed 2017·Granted Jun 30, 2020·12 cites·19 claims
- 2897US10174095B2Nucleic acid encoding a humanized anti-BCMA chimeric antigen receptorNOVARTIS AG·Filed 2015·Granted Jan 8, 2019·41 cites·50 claims
- 2997US9765156B2Enhancing activity of CAR T cells by co-introducing a bispecific antibodyUNIV PENNSYLVANIA·Filed 2013·Granted Sep 19, 2017·38 cites·12 claims
- 3097US9573988B2Effective targeting of primary human leukemia using anti-CD123 chimeric antigen receptor engineered T cellsBROGDON JENNIFER·Filed 2014·Granted Feb 21, 2017·87 cites·94 claims
- 3197US7754482B2Artificial antigen presenting cells and uses thereforUNIV PENNSYLVANIA·Filed 2005·Granted Jul 13, 2010·109 cites·2 claims
- 3297US7479269B2Methods for selectively enriching TH1 and TH2 cellsGENETICS INST LLC·Filed 2006·Granted Jan 20, 2009·32 cites·12 claims
- 3396US11203758B2Altering gene expression in modified T cells and uses thereofUNIV PENNSYLVANIA·Filed 2018·Granted Dec 21, 2021·12 cites·16 claims
- 3496US11090336B2Tn-MUC1 chimeric antigen receptor (CAR) T cell therapyUNIV PENNSYLVANIA·Filed 2020·Granted Aug 17, 2021·5 cites·10 claims
- 3596US11034749B2Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereofUNIV PENNSYLVANIA·Filed 2016·Granted Jun 15, 2021·10 cites·28 claims
- 3696US10253086B2CD20 therapies, CD22 therapies, and combination therapies with a CD19 chimeric antigen receptor (CAR)-expressing cellNOVARTIS AG·Filed 2016·Granted Apr 9, 2019·37 cites·35 claims
- 3796US10040846B2Compositions and methods for generating a persisting population of T cells useful for the treatment of cancerUNIV PENNSYLVANIA·Filed 2013·Granted Aug 7, 2018·39 cites·3 claims
- 3896US9394368B2Treatment of cancer using humanized anti-EGFRvIII chimeric antigen receptorBROGDON JENNIFER·Filed 2014·Granted Jul 19, 2016·112 cites·38 claims
- 3996US8637307B2Activation and expansion of T-cells using an engineered multivalent signaling platform as a research toolJUNE CARL H·Filed 2010·Granted Jan 28, 2014·143 cites·4 claims
- 4095US11208661B2Altering gene expression in modified T cells and uses thereofUNIV PENNSYLVANIA·Filed 2015·Granted Dec 28, 2021·8 cites·14 claims
- 4195US11084880B2Anti-BCMA chimeric antigen receptorNOVARTIS AG·Filed 2018·Granted Aug 10, 2021·15 cites·24 claims
- 4295US11028143B2Enhanced antigen presenting ability of RNA CAR T cells by co-introduction of costimulatory moleculesNOVARTIS AG·Filed 2015·Granted Jun 8, 2021·9 cites·16 claims
- 4395US10927184B2Treatment of cancer using humanized anti-CD19 chimeric antigen receptorNOVARTIS AG·Filed 2018·Granted Feb 23, 2021·10 cites·26 claims
- 4495US10603378B2Toxicity management for anti-tumor activity of CARsUNIV PENNSYLVANIA·Filed 2018·Granted Mar 31, 2020·10 cites·28 claims
- 4595US10357514B2Treatment of cancer using anti-CD19 Chimeric Antigen ReceptorUNIV PENNSYLVANIA·Filed 2015·Granted Jul 23, 2019·18 cites·45 claims
- 4695US10221245B2Treatment of cancer using humanized anti-CD19 chimeric antigen receptorNOVARTIS AG·Filed 2014·Granted Mar 5, 2019·36 cites·67 claims
- 4795US10117896B2Use of a trans-signaling approach in chimeric antigen receptorsUNIV PENNSYLVANIA·Filed 2013·Granted Nov 6, 2018·14 cites·1 claims
- 4895US9783591B2Use of the CD2 signaling domain in second-generation chimeric antigen receptorsUNIV PENNSYLVANIA·Filed 2013·Granted Oct 10, 2017·33 cites·2 claims
- 4995US9714278B2Use of ICOS-based CARs to enhance antitumor activity and CAR persistenceUNIV PENNSYLVANIA·Filed 2013·Granted Jul 25, 2017·34 cites·18 claims
- 5095US9572836B2Methods for assessing the suitability of transduced T cells for administrationUNIV PENNSYLVANIA·Filed 2013·Granted Feb 21, 2017·33 cites·14 claims
Showing the top 50 of 229 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Carl H. June files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →